Wrapmanager Inc Novo Nordisk A S Transaction History

Wrapmanager Inc

$382 Million
Q3 2024

A detailed history of Wrapmanager Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Wrapmanager Inc holds 12,083 shares of NVO stock, worth $1.06 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

12,083

Previous 14,211 14.97%

Holding current value

$1.06 Million

Previous $2.03 Million 29.09%

% of portfolio

0.38%

Previous 0.57%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$119.07 - $145.42 $253,380 - $309,453	-2,128 Reduced 14.97%	12,083 $1.44 Million
Q2 2024 Aug 08, 2024	SELL	$122.71 - $146.91 $208,484 - $249,600	-1,699 Reduced 10.68%	14,211 $2.03 Million
Q1 2024 May 09, 2024	SELL	$102.11 - $135.92 $291,421 - $387,915	-2,854 Reduced 15.21%	15,910 $2.04 Million
Q4 2023 Feb 07, 2024	BUY	$87.78 - $105.45 $113,938 - $136,874	1,298 Added 7.43%	18,764 $1.94 Million
Q3 2023 Nov 06, 2023	BUY	$90.94 - $199.54 $1.05 Million - $2.3 Million	11,526 Added 194.04%	17,466 $1.59 Million
Q2 2023 Aug 08, 2023	SELL	$155.98 - $172.65 $32,911 - $36,429	-211 Reduced 3.43%	5,940 $961,000
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $244,961 - $294,568	-1,851 Reduced 23.13%	6,151 $978,000
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $61,119 - $80,656	-596 Reduced 6.93%	8,002 $1.08 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $89,563 - $109,914	-940 Reduced 9.86%	8,598 $857,000
Q2 2022 Aug 05, 2022	SELL	$103.24 - $121.81 $3,819 - $4,506	-37 Reduced 0.39%	9,538 $1.06 Million
Q1 2022 May 10, 2022	BUY	$93.1 - $112.54 $27,743 - $33,536	298 Added 3.21%	9,575 $1.06 Million
Q4 2021 Feb 07, 2022	BUY	$95.88 - $117.08 $15,340 - $18,732	160 Added 1.75%	9,277 $1.04 Million
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $270,734 - $341,930	3,207 Added 54.26%	9,117 $875,000
Q2 2021 Aug 04, 2021	BUY	$67.66 - $84.76 $49,933 - $62,552	738 Added 14.27%	5,910 $495,000
Q1 2021 May 10, 2021	SELL	$67.06 - $75.82 $175,965 - $198,951	-2,624 Reduced 33.66%	5,172 $349,000
Q4 2020 Feb 08, 2021	BUY	$63.89 - $73.8 $12,586 - $14,538	197 Added 2.59%	7,796 $545,000
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $16,432 - $18,116	-258 Reduced 3.28%	7,599 $528,000
Q2 2020 Aug 11, 2020	SELL	$58.54 - $67.94 $1,346 - $1,562	-23 Reduced 0.29%	7,857 $514,000
Q1 2020 May 08, 2020	SELL	$49.46 - $64.78 $40,062 - $52,471	-810 Reduced 9.32%	7,880 $474,000
Q4 2019 Feb 11, 2020	BUY	$49.86 - $58.26 $135,070 - $157,826	2,709 Added 45.29%	8,690 $503,000
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $103,351 - $116,156	-2,174 Reduced 26.66%	5,981 $309,000
Q2 2019 Jul 31, 2019	BUY	$46.79 - $52.47 $39,116 - $43,864	836 Added 11.42%	8,155 $416,000
Q1 2019 May 06, 2019	BUY	$46.36 - $52.63 $24,617 - $27,946	531 Added 7.82%	7,319 $383,000
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $39,338 - $44,745	947 Added 16.21%	6,788 $313,000
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $15,664 - $17,165	335 Added 6.08%	5,841 $275,000
Q2 2018 Aug 03, 2018	BUY	$44.29 - $50.42 $243,860 - $277,612	5,506 New	5,506 $254,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.

Account